Skip to content

Clinical trials

Cardiotoxicity trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Country / region: Netherlands Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20102
20131
20202
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center3
The Netherlands Cancer Institute2
University Medical Center Groningen2
Catharina Ziekenhuis Eindhoven1
Children's Oncology Group1
Erasmus Medical Center1
Laurence J.C. van Warmerdam1
Stichting Hemato-Oncologie voor Volwassenen Nederland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity12
Breast Neoplasms8
Heart Failure4
Neoplasm Metastasis2
Cardiomyopathies1
Cardiovascular Diseases1
Dendritic Cell Sarcoma, Interdigitating1
Ischemia1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Non-Hodgkin1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.